Pancreatic Cancer Research

ResearcherAstellas Pharma (United States)Active in the last 2 years

Rupali M Fuldeore

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4336-9302; OpenAlex author ID A5025323612. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2026: 3 papers

Papers 3

  1. Healthcare resource utilization and economic burden of metastatic pancreatic cancer: a US commercial and Medicare claims analysis. Co-author DOI 10.1080/14796694.2026.2682510↗
  2. Understanding the symptoms and impacts of living with metastatic pancreatic adenocarcinoma: a prospective, noninterventional qualitative study. Co-author DOI 10.1093/oncolo/oyaf427↗
  3. Treatment patterns and outcomes of patients with a diagnosis of metastatic pancreatic adenocarcinoma in the United States, 2019-2024. Co-author DOI 10.3389/fonc.2026.1844261↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kenneth H. Yu · 1 shared paper, 2026 · strength 0.36
  2. Pegah Farrokhi · 1 shared paper, 2026 · strength 0.32
  3. David Dean Stenehjem · 1 shared paper, 2026 · strength 0.32
  4. Mok Oh · 1 shared paper, 2026 · strength 0.30
  5. Wungki Park · 1 shared paper, 2026 · strength 0.30

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.